American College of Gastroenterology Guidelines

Acute pancreatitis Microchapters

Home

American College of Gastroenterology Guidelines

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute Pancreatitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic criteria

History and Symptoms

Physical Examination

Laboratory Findings

Abdominal X Ray

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Approach to Therapy

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

American College of Gastroenterology Guidelines On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of American College of Gastroenterology Guidelines

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on American College of Gastroenterology Guidelines

CDC on American College of Gastroenterology Guidelines

American College of Gastroenterology Guidelines in the news

Blogs on American College of Gastroenterology Guidelines

Directions to Hospitals Treating Acute pancreatitis

Risk calculators and risk factors for American College of Gastroenterology Guidelines

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:  Tarek Nafee, M.D. [2]

## 2013 American College of Gastroenterology Guideline: Management of Acute Pancreatitis[1]

[edit | edit source]

### Diagnosis

[edit | edit source]

Recommendation  | Evidence Level  | Strength of Recommendation

|
|

The diagnosis of AP is most often established by the presence of two of the three following criteria: (i) abdominal pain consistent with the disease, (ii) serum amylase and/or lipase greater than three times the upper limit of normal, and/or (iii) characteristic findings from abdominal imaging.  | Moderate | Strong
Contrast-enhanced computed tomographic (CECT) and/or magnetic resonance imaging (MRI) of the pancreas should be reserved for patients in whom the diagnosis is unclear or who fail to improve clinically within the first 48-72h after hospital admission.  | Low | Strong

### Determining Etiology

[edit | edit source]

Recommendation  | Evidence Level  | Strength of Recommendation

|
|

Transabdominal ultrasound should be performed in all patients with acute pancreatitis  | Low | Strong
In the absence of gallstones and/or history of significant history of alcohol use, a serum triglyceride should be obtained and considered the etiology if >1,000 mg/dl | Moderate | Conditional
In a patient older than 40 years, a pancreatic tumor should be considered as a possible cause of acute pancreatitis  | Low | Conditional
Endoscopic investigation in patients with acute idiopathic pancreatitis should be limited, as the risks and benefits of investigation in these patients are unclear  | Low | Conditional
Patients with idiopathic pancreatitis should be referred to centers of expertise  | Low | Conditional
Genetic testing may be considered in young patients (<30 years old) if no cause is evident and a family history of pancreatic disease is present  | Low | Conditional

### Initial Assessment and Risk Stratification

[edit | edit source]

Recommendation  | Evidence Level  | Strength of Recommendation

|
|

Hemodynamic status should be assessed immediately upon presentation and resuscitative measures begun as needed  | Moderate | Strong
Risk assessment should be performed to stratify patients into higher- and lower-risk categories to assist triage, such as admission to an intensive care setting  | Moderate | Conditional
Patients with organ failure should be admitted to an intensive care unit or intermediary care setting whenever possible  | Low | Strong

### Initial Management

[edit | edit source]

Recommendation  | Evidence Level  | Strength of Recommendation

|
|

Aggressive hydration, defined as 250-500 ml per hour of isotonic crystalloid solution should be provided to all patients, unless cardiovascular and/or renal comorbidites exist. Early aggressive intravenous hydration is most beneficial the first 12–24 h, and may have little benefit beyond  | Moderate | Strong
In a patient with severe volume depletion, manifest as hypotension and tachycardia, more rapid repletion (bolus) may be needed  | Moderate | Conditional
Lactated Ringer's solution may be the preferred isotonic crystalloid replacement fluid  | Moderate | Conditional
Fluid requirements should be reassessed at frequent intervals within 6 h of admission and for the next 24–48 h. The goal of aggressive hydration should be to decrease the blood urea nitrogen  | Moderate | Strong

### Role of ERCP

[edit | edit source]

Recommendation  | Evidence Level  | Strength of Recommendation

|
|

Patients with acute pancreatitis and concurrent acute cholangitis should undergo ERCP within 24 h of admission  | Moderate | Strong
ERCP is not needed in most patients with gallstone pancreatitis who lack laboratory or clinical evidence of ongoing biliary obstruction  | Low | Strong
In the absence of cholangitis and/or jaundice, MRCP or endoscopic ultrasound (EUS) rather than diagnostic ERCP should be used to screen for choledocholithiasis if highly suspected  | Low | Conditional
Pancreatic duct stents and/or postprocedure rectal nonsteroidal anti-inflammatory drug (NSAID) suppositories should be utilized to prevent severe post-ERCP pancreatitis in high-risk patients | Moderate | Conditional

### Role of Antibiotics

[edit | edit source]

Recommendation  | Evidence Level  | Strength of Recommendation

|
|

Antibiotics should be given for an extrapancreatic infection, such as cholangitis, catheter-acquired infections, bacteremia, urinary tract infections, pneumonia  | High | Strong
Routine use of prophylactic antibiotics in patients with severe acute pancreatitis is not recommended | Moderate | Strong
The use of antibiotics in patients with sterile necrosis to prevent the development of infected necrosis is not recommended | Moderate | Strong
Infected necrosis should be considered in patients with pancreatic or extrapancreatic necrosis who deteriorate or fail to improve after 7–10 days of hospitalization. In these patients, either (i) initial CT-guided fine needle aspiration (FNA) for Gram stain and culture to guide use of appropriate antibiotics or (ii) empiric use of antibiotics without CT FNA should be given  | Low | Strong
In patients with infected necrosis, antibiotics known to penetrate pancreatic necrosis, such as carbapenems, quinolones, and metronidazole, may be useful in delaying or sometimes totally avoiding intervention, thus decreasing morbidity and mortality  | Low | Conditional
Routine administration of antifungal agents along with prophylactic or therapeutic antibiotics is not recommended  | Low | Conditional

### Nutrition in Acute Pancreatitis

[edit | edit source]

Recommendation  | Evidence Level  | Strength of Recommendation

|
|

In mild AP, oral feedings can be started immediately if there is no nausea and vomiting, and abdominal pain has resolved  | Moderate | Conditional
In mild AP, initiation of feeding with a low-fat solid diet appears as safe as a clear liquid diet | Moderate | Conditional
In severe AP, enteral nutrition is recommended to prevent infectious complications. Parenteral nutrition should be avoided unless the enteral route is not available, not tolerated, or not meeting caloric requirements  | High | Strong
Nasogastric delivery and nasojejunal delivery of enteral feeding appear comparable in efficacy and safety  | Moderate | Strong

### Role of Surgery

[edit | edit source]

Recommendation  | Evidence Level  | Strength of Recommendation

|
|

In patients with mild AP, found to have gallstones in the gallbladder, a cholecystectomy should be performed before discharge to prevent a recurrence of AP  | Moderate | Strong
In a patient with necrotizing biliary AP, in order to prevent infection, cholecystectomy is to be deferred until active inflammation subsides and fluid collections resolve or stabilize  | Moderate | Strong
The presence of asymptomatic pseudocysts and pancreatic and/or extrapancreatic necrosis do not warrant intervention, regardless of size, location, and/or extension  | Moderate | Strong
In stable patients with infected necrosis, surgical, radiologic, and/or endoscopic drainage should be delayed preferably for more than 4 weeks to allow liquefication of the contents and the development of a fibrous wall around the necrosis (walled-off necrosis) | Low | Strong
In symptomatic patients with infected necrosis, minimally invasive methods of necrosectomy are preferred to open necrosectomy  | Low | Strong

## References

[edit | edit source]

1. ↑ Tenner S, Baillie J, DeWitt J, Vege SS, American College of Gastroenterology (2013). "American College of Gastroenterology guideline: management of acute pancreatitis". Am J Gastroenterol. 108 (9): 1400–15, 1416. doi:10.1038/ajg.2013.218. PMID 23896955.CS1 maint: Multiple names: authors list (link)

Template:WSTemplate:WH